Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence Study of Gliclazide 60 mg Modified Release Tablets in Healthy Thai Volunteers under Fasting and Fed Conditions
TCTR20170810006Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of gliclazide in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by International Bio Service. Planned start Oct 2017; status: not yet recruiting.
02
Drugs
gliclazide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on TCTR20170810006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20170810006.